Skip to main content
Premium Trial:

Request an Annual Quote

Nothing Is Sacred

At Nature, Retraction Watch bloggers Adam Marcus and Ivan Oransky write that the increase in retractions of scientific papers isn't necessarily a bad thing, and that the trend shows instead that journal editors and researchers need to stop treating papers as if they are "sacred." Instead of focusing on an individual paper, the record of scientific study on a particular subject should include other material like media coverage, blog posts, and how many times a paper has been downloaded, Marcus and Oransky write. It's also important that journal editors and researchers embrace the idea of post-publication peer review. "We see many papers retracted now that may not need to be, but they contain some nuances that editors don't know how to handle," Marcus and Oransky write. "In the new system, a fleshed-out addendum, or correction, could suffice if the paper included some of the post-publication discussion." Such a system could, in fact, lead to a decline in retractions, and a rise in the quality of papers published, they add.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.